Product
Bictegravir/Emtricitabine/Tenofovir Alafenamide
Aliases
Biktarvy
2 clinical trials
2 indications
Indication
HIV/AIDSIndication
HIV-1 infectionClinical trial
Prospective Pilot Study of the Efficacy, Safety and Tolerability of Bictegravir-Based HIV ART Same-Day Treatment Evaluations (B-HASTE)Status: Terminated, Estimated PCD: 2023-07-01
Clinical trial
A Phase 4, Single-Arm Study of the Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Patients With Active Illicit Substance UseStatus: Completed, Estimated PCD: 2021-10-01